MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-23-0004157
Market Cap
₹37.35 Cr
VSCL-SM · NSE
Share Price
₹24.50
-1.61% today
Revenue
₹45.78 Cr
FY 2025-26 · +20.8% YoY
EBITDA
₹0.76 Cr
Margin 1.7%
Net Profit
−₹1.88 Cr
FY 2025-26 · +79.5% YoY
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹15 Cr
Issued & subscribed
Open charges
₹26.44 Cr
Satisfied ₹65.11 Cr
About Vadivarhe Speciality Chemicals Limited
Data last updated:
Vadivarhe Speciality Chemicals Limited is a public limited company based in Igatpuri, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 23 February 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24100MH2009PLC190516. Its GSTIN is 27AACCV9569J1ZK (Maharashtra). It is a listed company as per MCA records. Its shares are listed on NSE: VSCL.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹15 Cr. It is led by directors including Meena Sunil Pophale (Whole-Time Director) and Ravindra Keshav Paranjpe.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Gat No. 204 Vadivarhe, Igatpuri, Maharashtra, India – 422403.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹45.78 Cr, a growth of 20.8% compared to the previous year. For the same year it recorded a net loss of ₹1.88 Cr (net margin -4.1%) and EBITDA of ₹76 Lakh (EBITDA margin 1.7%). Total assets are valued at ₹27.85 Cr (down 17.4% YoY).
The company has about 70 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: VSCL. As per MCA filings, the company has open charges of ₹26.44 Cr and satisfied charges of ₹65.11 Cr on record. Court records list 8 cases involving the company, including 5 filed by the company and 3 filed against it; 2 cases are pending. The company has 10 deals on record (9 market trades, 1 ipo); the latest was in October 2024. Its 7 peer companies in the Chemicals industry (API Manufacturers, Organic Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 2 smaller; the largest is G D Dyestuff Industries Limited with revenue of ₹39.05 Cr.
Vadivarhe Speciality Chemicals Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-23-0004157). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vscl.in.
Company details
CIN L24100MH2009PLC190516
Registration Number 190516
Incorporation Date 23 February 2009
ROC Mumbai
Listing Status Listed (NSE: VSCL)
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-23-0004157
CIN history
Vadivarhe Speciality Chemicals has one previous CIN (Corporate Identification Number): U24100MH2009PLC190516. The current CIN is L24100MH2009PLC190516, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24100MH2009PLC190516 | Current |
| U24100MH2009PLC190516 | Previous |
Key People
Meena Sunil Pophale Whole-Time Director Ravindra Keshav Paranjpe Director Prasanna Prabhakar Rege Director Recognitions & Rankings of Vadivarhe Speciality Chemicals
Contact details
Vadivarhe Speciality Chemicals Limited's registered office is in Igatpuri, Maharashtra. Its website is vscl.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressGat No. 204 Vadivarhe, Igatpuri, Maharashtra, India – 422403
- IndustryPharma, API Manufacturers
To see the full contact details of Vadivarhe Speciality Chemicals Limited, buy the company report.
Comprehensive company report
Vadivarhe Speciality Chemicals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Vadivarhe Speciality Chemicals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vadivarhe Speciality Chemicals Limited, buy the company report.
Financials of Vadivarhe Speciality Chemicals Limited
FY 2025-26 filings availableVadivarhe Speciality Chemicals Limited reported revenue of ₹45.78 Cr (up 20.8% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹45.78 Cr
+20.8% YoY
EBITDA
₹0.76 Cr
+112.6% YoY
Profit After Tax
−₹1.88 Cr
+79.5% YoY
Net Worth
−₹4.42 Cr
-59.0% YoY
Total Assets
₹27.85 Cr
-17.4% YoY
Total Debt
₹31.77 Cr
-11.8% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 45.78 | 37.91 | 40.08 | 43.68 | 21.45 | 26.47 | 28.58 |
| Revenue growth | +20.8% | -5.4% | -8.2% | +103.6% | -19.0% | -7.4% | - |
| EBITDA | 0.76 | (6.02) | 4.57 | 3.45 | (6.80) | (0.54) | (9.23) |
| EBITDA margin | +1.7% | -15.9% | +11.4% | +7.9% | -31.7% | -2.0% | -32.3% |
| Profit before tax | (1.63) | (9.26) | 1.49 | 1.15 | (9.61) | (2.59) | (11.97) |
| Net profit | (1.88) | (9.18) | 0.06 | 0.79 | (9.86) | (3.51) | (9.95) |
| Net profit margin | -4.1% | -24.2% | +0.2% | +1.8% | -46.0% | -13.3% | -34.8% |
| EPS (₹) | (1.28) | (7.25) | 0.05 | 0.90 | (7.52) | (2.16) | (7.70) |
| Balance sheet | |||||||
| Total assets | 27.85 | 33.72 | 33.13 | 33.78 | 30.37 | 38.93 | 37.99 |
| Net worth | (4.42) | (2.78) | 6.49 | 6.42 | 5.28 | 14.89 | 17.65 |
| Total debt | 31.77 | 36.03 | 26.18 | 26.94 | 24.42 | 23.45 | 19.67 |
| Cash & bank | 0.69 | 0.57 | 0.52 | 0.81 | 0.80 | 0.98 | 0.66 |
| Net working capital | 6.25 | 10.90 | 9.53 | 7.52 | 3.02 | 10.70 | 7.69 |
| Cash flow | |||||||
| Cash from operations | 6.36 | (7.15) | 2.26 | (0.35) | 1.24 | (0.28) | 4.10 |
| Cash from investing | (0.63) | (1.32) | (0.51) | (0.69) | (0.82) | 0.02 | (1.68) |
| Cash from financing | (5.61) | 8.53 | (2.04) | 1.05 | (0.60) | 0.58 | (2.34) |
| Particulars | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.92 | 5.71 | 5.59 | 4.23 | 8.24 | 4.37 | 6.49 | 7.37 |
| Revenue growth (YoY) | -28.2% | +30.7% | -13.9% | -42.6% | +17.2% | - | - | - |
| Other income | 0.04 | 0.30 | 0.29 | 0.04 | 0.11 | 0.07 | 0.89 | 0.01 |
| Total expenses | 7.88 | 8.09 | 7.09 | 5.30 | 8.16 | 4.61 | 6.97 | 7.35 |
| EBITDA | (1.96) | (2.38) | (1.50) | (1.07) | 0.08 | (0.24) | (0.48) | 0.02 |
| EBITDA margin | -33.1% | -41.7% | -26.8% | -25.3% | +1.0% | -5.5% | -7.4% | +0.3% |
| Depreciation | 0.44 | 0.45 | 0.46 | 0.45 | 0.45 | 0.46 | 0.46 | 0.44 |
| Interest | 0.34 | 0.36 | 0.48 | 0.38 | 0.34 | 0.30 | 0.29 | 0.30 |
| Profit before tax | (2.70) | (2.89) | (2.15) | (1.86) | (0.60) | (0.93) | (0.34) | (0.71) |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 22 Oct 2026
| Particulars | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.92 | 5.71 | 5.59 | 4.23 | 8.24 | 4.37 | 6.49 | 7.37 |
| Revenue growth (YoY) | -28.2% | +30.7% | -13.9% | -42.6% | +17.2% | - | - | - |
| Other income | 0.04 | 0.30 | 0.29 | 0.04 | 0.11 | 0.07 | 0.89 | 0.01 |
| Total expenses | 7.88 | 8.09 | 7.09 | 5.30 | 8.16 | 4.61 | 6.97 | 7.35 |
| EBITDA | (1.96) | (2.38) | (1.50) | (1.07) | 0.08 | (0.24) | (0.48) | 0.02 |
| EBITDA margin | -33.1% | -41.7% | -26.8% | -25.3% | +1.0% | -5.5% | -7.4% | +0.3% |
| Depreciation | 0.44 | 0.45 | 0.46 | 0.45 | 0.45 | 0.46 | 0.46 | 0.44 |
| Interest | 0.34 | 0.36 | 0.48 | 0.38 | 0.34 | 0.30 | 0.29 | 0.30 |
| Profit before tax | (2.70) | (2.89) | (2.15) | (1.86) | (0.60) | (0.93) | (0.34) | (0.71) |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 45.78 | 37.91 | 40.08 | 43.68 | 21.45 | 26.47 | 28.58 |
| Revenue growth | +20.8% | -5.4% | -8.2% | +103.6% | -19.0% | -7.4% | - |
| Other income | 0.95 | 0.33 | 0.49 | 1.10 | 0.67 | 1.08 | 0.38 |
| Total expenses | 45.02 | 43.93 | 35.51 | 40.23 | 28.25 | 27.01 | 37.81 |
| Employee cost | 0.72 | 0.70 | 0.69 | 0.62 | 0.66 | 0.46 | 0.75 |
| EBITDA | 0.76 | (6.02) | 4.57 | 3.45 | (6.80) | (0.54) | (9.23) |
| EBITDA margin | +1.7% | -15.9% | +11.4% | +7.9% | -31.7% | -2.0% | -32.3% |
| Depreciation | 1.85 | 1.85 | 1.74 | 1.79 | 1.79 | 1.81 | 1.75 |
| Interest | 1.49 | 1.72 | 1.83 | 1.61 | 1.69 | 1.32 | 1.37 |
| Profit before tax | (1.63) | (9.26) | 1.49 | 1.15 | (9.61) | (2.59) | (11.97) |
| Tax | 0.00 | 0.00 | 1.45 | 0.00 | 0.00 | 0.17 | (2.15) |
| Net profit | (1.88) | (9.18) | 0.06 | 0.79 | (9.86) | (3.51) | (9.95) |
| Net profit margin | -4.1% | -24.2% | +0.2% | +1.8% | -46.0% | -13.3% | -34.8% |
| EPS (₹) | (1.28) | (7.25) | 0.05 | 0.90 | (7.52) | (2.16) | (7.70) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 12.78 | 12.78 | 12.78 | 12.78 | 12.78 | 12.78 | 12.78 |
| Reserves & surplus | (17.20) | (15.56) | (6.29) | (6.36) | (7.50) | 2.11 | 4.87 |
| Shareholders' funds (net worth) | (4.42) | (2.78) | 6.49 | 6.42 | 5.28 | 14.89 | 17.65 |
| Secured loans | 17.69 | 18.62 | 11.33 | 8.45 | 10.56 | 15.55 | 15.85 |
| Unsecured loans | 14.08 | 17.41 | 14.85 | 18.49 | 13.86 | 7.90 | 3.82 |
| Total debt | 31.77 | 36.03 | 26.18 | 26.94 | 24.42 | 23.45 | 19.67 |
| Total liabilities | 27.85 | 33.72 | 33.13 | 33.78 | 30.37 | 38.93 | 37.99 |
| Assets | |||||||
| Gross block | 43.63 | 43.42 | 41.23 | 41.39 | 40.57 | 40.48 | 37.90 |
| Net block | 21.07 | 22.43 | 21.59 | 23.37 | 24.32 | 25.98 | 25.20 |
| Capital work in progress | 0.19 | 0.08 | 1.56 | 0.99 | 1.09 | 0.33 | 2.81 |
| Investments | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Inventories | 7.94 | 9.72 | 8.58 | 8.57 | 6.82 | 3.34 | 6.83 |
| Sundry debtors | 8.11 | 8.26 | 4.94 | 5.77 | 2.02 | 9.11 | 8.17 |
| Cash & bank balances | 0.69 | 0.57 | 0.52 | 0.81 | 0.80 | 0.98 | 0.66 |
| Loans & advances | 0.43 | 1.35 | 3.97 | 5.03 | 4.69 | 5.52 | 5.36 |
| Total current assets | 17.17 | 19.90 | 18.01 | 20.18 | 14.33 | 18.95 | 21.02 |
| Total current liabilities | 10.92 | 9.00 | 8.48 | 12.66 | 11.31 | 8.25 | 13.33 |
| Net working capital | 6.25 | 10.90 | 9.53 | 7.52 | 3.02 | 10.70 | 7.69 |
| Total assets | 27.85 | 33.72 | 33.13 | 33.78 | 30.37 | 38.93 | 37.99 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.57 | 0.52 | 0.81 | 0.80 | 0.98 | 0.66 | 0.58 |
| Net cash from operating activities | 6.36 | (7.15) | 2.26 | (0.35) | 1.24 | (0.28) | 4.10 |
| Net cash from investing activities | (0.63) | (1.32) | (0.51) | (0.69) | (0.82) | 0.02 | (1.68) |
| Net cash from financing activities | (5.61) | 8.53 | (2.04) | 1.05 | (0.60) | 0.58 | (2.34) |
| Net change in cash | 0.12 | 0.05 | (0.29) | 0.00 | (0.18) | 0.32 | 0.08 |
| Closing cash | 0.69 | 0.57 | 0.52 | 0.81 | 0.80 | 0.98 | 0.66 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +20.8% | -5.4% | -8.2% | +103.6% | -19.0% | -7.4% | - |
| EBITDA growth | +112.6% | -231.7% | +32.5% | +150.7% | -1159.3% | +94.2% | - |
| PBT growth | +82.4% | - | +29.6% | +9998.0% | -271.0% | +78.4% | - |
| Net income growth | +79.5% | - | -92.4% | +108.0% | -180.9% | +64.7% | - |
| Revenue CAGR (3Y) | +1.6% | +20.9% | +14.8% | +15.2% | -12.8% | +1.2% | -6.6% |
| EBITDA CAGR (3Y) | -39.6% | -4.0% | - | - | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | -3.6% | -24.4% | +0.1% | +2.6% | -44.8% | -10.4% | -34.4% |
| Return on capital employed | 0.0% | 0.0% | +7.3% | +6.3% | 0.0% | 0.0% | 0.0% |
| Return on net worth | 0.0% | 0.0% | +0.3% | +6.6% | 0.0% | 0.0% | 0.0% |
| Debt / equity | 0.00 | 16.77 | 4.11 | 4.39 | 2.37 | 1.33 | 0.90 |
| Long-term debt / equity | 0.00 | 11.24 | 2.72 | 2.75 | 1.51 | 0.76 | 0.51 |
| Interest cover | -136.70 | -21.86 | 64.66 | 96.99 | -19.67 | -56.17 | -12.48 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.05 | 0.90 | 0.97 | 1.07 | 0.53 | 0.68 | 0.76 |
| Inventory turnover | 5.18 | 4.14 | 4.67 | 5.68 | 4.22 | 5.21 | 4.26 |
| Debtors turnover | 5.59 | 5.74 | 7.48 | 11.21 | 3.85 | 3.06 | 2.74 |
| EPS (₹) | (1.28) | (7.25) | 0.05 | 0.90 | (7.52) | (2.16) | (7.70) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | (3.45) | (2.17) | 5.08 | 5.03 | 4.13 | 11.65 | 13.81 |
To see the full year-wise statements and ratios of Vadivarhe Speciality Chemicals Limited, buy the company report.
Board of directors of Vadivarhe Speciality Chemicals Limited
Vadivarhe Speciality Chemicals has 5 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meena Sunil Pophale Also directs: Pophale International LLP | Whole-Time Director | 23 Feb 2009 | 17 Years 8 Months | Current |
| Ravindra Keshav Paranjpe | Director | 02 May 2017 | 9 Years 5 Months | Current |
| Prasanna Prabhakar Rege | Director | 02 May 2017 | 9 Years 5 Months | Current |
| Uttara Adwait Kher | Director | 02 May 2017 | 9 Years 5 Months | Current |
| Sunil Haripant Pophale | Director | 23 Feb 2009 | 17 Years 8 Months | Current |
Peer comparison
Vadivarhe Speciality Chemicals Limited is compared with the 7 companies closest to it by revenue in the Chemicals industry (API Manufacturers, Organic Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vadivarhe Speciality Chemicals Limitedthis company | ₹45.78 Cr (FY 2026) | -₹1.88 Cr | -4.1% | 20.8% | 70 | Igatpuri, Maharashtra, India |
| G D Dyestuff Industries Limited | ₹39.05 Cr (FY 2024) | -59.0% | New Delhi, Delhi, India | |||
| Sujata Nutri-Pharma Private Limited | ₹39.05 Cr (FY 2025) | 5.0% | Vadodara, Gujarat, India | |||
| Nebula Healthcare Limited | ₹38.59 Cr (FY 2025) | 4.0% | Ahmedabad, Gujarat, India | |||
| Eiko Lifesciences Limited | ₹38.38 Cr (FY 2025) | 37.0% | Thane, Maharashtra, India | |||
| Almon Healthcare Private Limited | ₹38.26 Cr (FY 2025) | 58.0% | Ahmedabad, Gujarat, India | |||
| Ad-Pharmachem Private Limited | ₹37.8 Cr (FY 2024) | -15.0% | Aurangabad, Maharashtra, India | |||
| Ceyone Life Sciences Private Limited | ₹37.68 Cr (FY 2025) | 63.0% | Anakapalle, Andhra Pradesh, India |
To see the full peer comparison of Vadivarhe Speciality Chemicals Limited, buy the company report.
Auditor
Vadivarhe Speciality Chemicals Limited is audited by BHALCHANDRA D KARVE & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHALCHANDRA D KARVE & ASSOCIATES | FY 2024 | 135281W |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 71.70%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 28.30%.
Sep 2026
QUARTER
71.70% Promoters
28.30% Retail & Others
Promoter holding - history
Now 71.70% · Sep 2026High 71.70% · Sep 2026Low 66.80% · Dec 2025
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 71.70% | 66.80% | 66.80% | 66.80% |
| Public | 28.30% | 33.20% | 33.20% | 33.20% |
Charges & borrowings
Open charges
₹26.44 Cr
Satisfied charges
₹65.11 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 May 2026 | 101312251 | Others | ₹2.23 Cr | Open | |
| 12 Aug 2024 | 100972938 | Others | ₹23.85 Cr | Open | |
| 29 Apr 2024 | 100911264 | Bank of India | ₹30 Lakh | Open | |
| 02 Apr 2024 | 100896391 | Bank of India | ₹6 Lakh | Open | |
| 27 Feb 2025 | 101079752 | Others | ₹4 Cr | Satisfied |
To see the full charge records of Vadivarhe Speciality Chemicals Limited, buy the company report.
Total charge records: 26 View all charges
Deals & funding
Vadivarhe Speciality Chemicals Limited has 10 deals on record (9 market trades, 1 ipo); the latest was in October 2024.
Total deals
10
Market trades
9
IPO
1
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2024 | Market trade | ₹74.3 Lakh | Buyer: an individual Seller: an individual |
| Sep 2024 | Market trade | ₹2.01 Cr | Buyer: an individual Seller: an individual |
| Sep 2024 | Market trade | ₹3.13 Cr | Buyer: NNM Securities Private Limited , 2 individuals Seller: 3 individuals |
| Mar 2023 | Market trade | ₹47.1 Lakh | Seller: Hem Finlease Pvt Ltd |
| Mar 2019 | Market trade | ₹48.6 Lakh | Buyer: an individual Seller: Astute Investment Management Private Limited |
To see the full deal history of Vadivarhe Speciality Chemicals Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Vadivarhe Speciality Chemicals Limited has 8 court cases on record: 5 filed by Vadivarhe Speciality Chemicals, 3 filed against it. 2 cases are pending and 6 are disposed.
Total cases
8
Filed by the company
5
Filed against the company
3
Pending
2
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 3 | 1 |
| High courts | 1 | 0 | 1 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Nashik, Maharashtra | Civil suit | Filed by the company against Acura Labs Pvt Ltd THR Surya Pradeep Nimmagadda | Pending |
| District court, Nashik, Maharashtra | Civil suit | Filed by the company against Ms Batchmaster Software Pvt Ltd | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| District court, Nashik, Maharashtra | Civil suit | Filed by the company against an individual | Disposed |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Revision Application (ULP)) | Filed against the company by an individual | Disposed |
To see the full case history of Vadivarhe Speciality Chemicals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vadivarhe Speciality Chemicals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vadivarhe Speciality Chemicals Limited has a workforce of 70 employees on its EPFO records as of Apr 02, 2025, across 1 active EPFO establishment.
Employee count
70
Active EPFO establishments
1
Employee growth
2.94%
GST
Vadivarhe Speciality Chemicals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCV9569J1ZK | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vadivarhe Speciality Chemicals Limited, buy the company report.
Recent activity
Vadivarhe Speciality Chemicals Limited has 31 board changes on record since 2009: 18 appointments and 13 cessations. The latest: Anil Ganpat Suryavanshi ceased to be Whole-Time Director on 09 Jun 2025.
Charges
A charge with Others amounted to Rs. 2.23 Cr with Charge ID 101312251 was registered on 16 May 2026.
Filing
Vadivarhe Speciality Chemicals Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai Ii.
Charges
A charge registered on 27 Feb 2025 via Charge ID 101079752 with Others was fully satisfied on 23 Mar 2026.
Charges
A charge with Others of Rs. 23.85 Cr registered on 12 Aug 2024 with Charge ID 100972938 was modified on 09 Mar 2026.
AGM
Vadivarhe Speciality Chemicals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Ceased
Anil Ganpat Suryavanshi ceased to be Whole-Time Director.
Ceased
Susheel Koul ceased to be CEO.
Charges
A charge with Others amounted to Rs. 4.00 Cr with Charge ID 101079752 was registered on 27 Feb 2025.
Charges
A charge registered on 26 Jul 2023 via Charge ID 100792466 with Bank Of India was fully satisfied on 20 Jan 2025.
Charges
A charge registered on 26 Jul 2023 via Charge ID 100792467 with Bank Of India was fully satisfied on 20 Jan 2025.
Charges
A charge registered on 26 Jul 2023 via Charge ID 100792458 with Bank Of India was fully satisfied on 24 Oct 2024.
Charges
A charge registered on 26 Jul 2023 via Charge ID 100792461 with Bank Of India was fully satisfied on 24 Oct 2024.
79 earlier events are in the company report.
News
Frequently asked questions
Vadivarhe Speciality Chemicals is an active public limited company based in Igatpuri, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 23 February 2009 (17+ years old) and is registered under CIN L24100MH2009PLC190516. Listed on NSE: VSCL.
Vadivarhe Speciality Chemicals reported revenue of ₹45.78 Cr for FY 2025-26 (up 20.8% YoY) based on standalone financials.
Vadivarhe Speciality Chemicals has 5 current directors:
- Meena Sunil Pophale - Whole-Time Director
- Ravindra Keshav Paranjpe - Director
- Prasanna Prabhakar Rege - Director
- Uttara Adwait Kher - Director
- Sunil Haripant Pophale - Director
The latest financial statements of Vadivarhe Speciality Chemicals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vadivarhe Speciality Chemicals is 27AACCV9569J1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Vadivarhe Speciality Chemicals is L24100MH2009PLC190516. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Vadivarhe Speciality Chemicals is a listed company as per MCA records. Its shares are listed on NSE (symbol: VSCL).
Vadivarhe Speciality Chemicals has 8 court cases on record: 5 filed by the company and 3 filed against it. 2 are pending. Most are in the district courts.
Vadivarhe Speciality Chemicals was incorporated on 23 February 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
Vadivarhe Speciality Chemicals has 10 deals on record (9 market trades, 1 ipo); the latest was in October 2024.
The peers of Vadivarhe Speciality Chemicals by revenue are G D Dyestuff Industries Limited, Sujata Nutri-Pharma Private Limited, Nebula Healthcare Limited, Eiko Lifesciences Limited, Almon Healthcare Private Limited and 2 more, all in the Chemicals industry (API Manufacturers, Organic Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).